The San Francisco Chronicle mentions our investor partnership in their recent article. Here’s an excerpt from the story:

“Separately, the Apothecarium of San Francisco, which operates three dispensaries in the city and one in Las Vegas, agreed to sell itself for $118 million in cash and stock to TerrAscend, a Toronto cannabis producer licensed in Canada and some U.S. states.”

Read the full story here.